Fortis Malar Hospitals Limited (BOM:523696)
India · Delayed Price · Currency is INR 47.33
-0.44 (-0.92%)
At close: Aug 21, 2026
Fortis Malar Hospitals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 0.32 | 0.51 | - | 590.09 | 859.51 | 861.78 | |
Revenue Growth | 53.66% | - | - | -31.35% | -0.26% | 24.46% |
Cost of Revenue | 1.44 | 1.27 | 4.11 | 270.85 | 363.54 | 388.35 |
Gross Profit | -1.13 | -0.76 | -4.11 | 319.24 | 495.97 | 473.43 |
Selling, General & Admin | 3.04 | 3.04 | 2.95 | 6.04 | 9.9 | 10.79 |
Other Operating Expenses | 11.73 | 11.97 | 14.32 | 323.61 | 437.66 | 428.27 |
Operating Expenses | 14.77 | 15 | 17.28 | 423.25 | 569.03 | 564.37 |
Operating Income | -15.9 | -15.76 | -21.39 | -104 | -73.06 | -90.94 |
Interest Expense | - | - | -0.1 | -40.62 | -60.71 | -65.58 |
Interest & Investment Income | 21.67 | 21.67 | 25 | 55.94 | 62.77 | 70.65 |
Other Non Operating Income (Expenses) | -40.73 | - | -0.01 | -2.43 | - | - |
EBT Excluding Unusual Items | -34.95 | 5.92 | 3.51 | -91.11 | -71 | -85.87 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.48 |
Other Unusual Items | 41.34 | 41.34 | 2.17 | 591.21 | 0.92 | 2.77 |
Pretax Income | 6.4 | 47.26 | 5.68 | 500.1 | -70.08 | -82.61 |
Income Tax Expense | 5.03 | 5.89 | 1.76 | 46.85 | 84.73 | 0.12 |
Net Income | 1.37 | 41.37 | 3.92 | 453.25 | -154.81 | -82.74 |
Net Income to Common | 1.37 | 41.37 | 3.92 | 453.25 | -154.81 | -82.74 |
Net Income Growth | -97.03% | 955.46% | -99.13% | - | - | - |
Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 19 | 19 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 19 | 19 |
Shares Change | 4.44% | - | - | - | - | - |
EPS (Basic) | 0.07 | 2.21 | 0.21 | 24.18 | -8.26 | -4.41 |
EPS (Diluted) | 0.07 | 2.21 | 0.21 | 24.18 | -8.26 | -4.41 |
EPS Growth | -97.16% | 955.46% | -99.13% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 6.25 | 15.44 | -96.02 | 37.32 | 54.37 |
Free Cash Flow Per Share | - | 0.33 | 0.82 | -5.12 | 1.99 | 2.90 |
Dividend Per Share | - | - | - | 42.500 | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | - | -147.75% | - | 54.10% | 57.70% | 54.94% |
Operating Margin | -5046.03% | -3083.76% | - | -17.63% | -8.50% | -10.55% |
Profit Margin | 434.60% | 8096.67% | - | 76.81% | -18.01% | -9.60% |
Free Cash Flow Margin | - | 1222.31% | - | -16.27% | 4.34% | 6.31% |
EBITDA | - | - | 1.81 | -80.81 | -38.94 | -57.25 |
EBITDA Margin | - | - | - | -13.69% | -4.53% | -6.64% |
D&A For EBITDA | - | - | 23.2 | 23.2 | 34.11 | 33.69 |
EBIT | -15.9 | -15.76 | -21.39 | -104 | -73.06 | -90.94 |
EBIT Margin | - | - | - | -17.63% | -8.50% | -10.55% |
Effective Tax Rate | 78.60% | 12.45% | 31.00% | 9.37% | - | - |
Revenue as Reported | 22.61 | 63.53 | 27.17 | 659.6 | 925.89 | 935.69 |
Advertising Expenses | - | 1.59 | 0.64 | - | - | - |